Immuron Limited (NASDAQ: IMRN) details ASX quotation of securities, cleansing notice

Rhea-AI Filing Summary

Immuron Limited submitted a report as a foreign private issuer to share information it had already released on the Australian Securities Exchange. The report attaches two December 11, 2025 ASX announcements: an application for quotation of securities and a cleansing notice. These documents are furnished to U.S. regulators for information purposes and are not automatically incorporated into other U.S. securities law filings unless specifically referenced later.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the Month of December 2025

Commission File Number: 001-38104

IMMURON LIMITED

(Name of Registrant)

Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒       Form 40-F ☐

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐       No ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-

IMMURON LIMITED

EXPLANATORY NOTE

Immuron Limited (the “Company”) published two announcements (the “Public Notices”) to the Australian Securities Exchange on December 11, 2025 titled:

99.1		Application for quotation of securities
99.2		Cleansing Notice

A copy of the Public Notice is attached as an exhibit to this report on Form 6-K.

This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

1

EXHIBITS

Exhibit Number		Description
99.1		Application for quotation of securities
99.2		Cleansing Notice

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	IMMURON LIMITED
Date: December 12, 2025	By:	/s/ Phillip Hains
		Phillip Hains
		Company Secretary

3

FAQ

What did Immuron Limited (IMRN) report in its December 2025 6-K?

Immuron Limited reported that it had published two announcements on the Australian Securities Exchange and furnished copies of those announcements as exhibits to its report.

Which ASX announcements are attached to Immuron Limited's 6-K for IMRN?

The report includes two ASX announcements dated December 11, 2025: an Application for quotation of securities and a Cleansing Notice, each attached as an exhibit.

How are the ASX announcements labeled in Immuron Limited's 6-K exhibits?

The announcements are labeled as Exhibit 99.1, titled Application for quotation of securities, and Exhibit 99.2, titled Cleansing Notice.

Does Immuron Limited’s December 2025 report automatically update its other U.S. securities filings?

No. The report states that it is not deemed to be filed for purposes of the Exchange Act and will not be incorporated by reference into other U.S. securities filings unless expressly stated in those filings.

Who signed Immuron Limited's December 2025 6-K and in what capacity?

The report was signed on behalf of Immuron Limited by Phillip Hains, acting as Company Secretary, dated December 12, 2025.

What is the purpose of Immuron Limited furnishing ASX announcements to U.S. investors?

By furnishing the ASX announcements as exhibits, Immuron Limited makes the same information available to U.S. market participants that it released on the Australian Securities Exchange.